Sara Solt

3.1k total citations · 1 hit paper
9 papers, 1.9k citations indexed

About

Sara Solt is a scholar working on Oncology, Immunology and Biotechnology. According to data from OpenAlex, Sara Solt has authored 9 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 3 papers in Biotechnology. Recurrent topics in Sara Solt's work include Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Immunotherapy and Immune Responses (6 papers). Sara Solt is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Immunotherapy and Immune Responses (6 papers). Sara Solt collaborates with scholars based in United States. Sara Solt's co-authors include Elizabeth M. Jaffee, Eric R. Lutz, Beth Onners, Dung T. Le, Elizabeth A. Sugar, Daniel A. Laheru, Lanqing Huang, Theodore Kouo, Alexandra B. Pucsek and Todd D. Armstrong and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Clinical Cancer Research.

In The Last Decade

Sara Solt

9 papers receiving 1.9k citations

Hit Papers

Galectin-3 Shapes Antitumor Immune Responses by Suppressi... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
    2015 415 citations Theodore Kouo, Lanqing Huang et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Solt United States 8 1.6k 1.2k 288 144 139 9 1.9k
Beth Onners United States 10 1.1k 0.7× 761 0.6× 175 0.6× 117 0.8× 113 0.8× 16 1.2k
Mona Møller Norway 7 588 0.4× 525 0.4× 364 1.3× 102 0.7× 139 1.0× 7 964
Sylvia M. Lee United States 13 986 0.6× 733 0.6× 328 1.1× 90 0.6× 28 0.2× 19 1.3k
Aniruddha Choudhury Sweden 20 909 0.6× 1.2k 0.9× 460 1.6× 74 0.5× 50 0.4× 38 1.7k
Toby Mellows United Kingdom 12 885 0.5× 643 0.5× 357 1.2× 222 1.5× 34 0.2× 17 1.5k
Frank M. Speetjens Netherlands 20 617 0.4× 613 0.5× 326 1.1× 87 0.6× 35 0.3× 50 1.1k
Isaac Kriley United States 5 983 0.6× 744 0.6× 297 1.0× 84 0.6× 47 0.3× 9 1.2k
Matilde D’Asaro Italy 8 686 0.4× 919 0.7× 242 0.8× 159 1.1× 30 0.2× 10 1.3k
An Coosemans Belgium 21 523 0.3× 545 0.4× 409 1.4× 238 1.7× 41 0.3× 76 1.6k
Gavin Bendle United Kingdom 17 1.2k 0.7× 1.0k 0.8× 342 1.2× 54 0.4× 42 0.3× 29 1.5k

Countries citing papers authored by Sara Solt

Since Specialization
Citations

This map shows the geographic impact of Sara Solt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Solt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Solt more than expected).

Fields of papers citing papers by Sara Solt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Solt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Solt. The network helps show where Sara Solt may publish in the future.

Co-authorship network of co-authors of Sara Solt

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Solt. A scholar is included among the top collaborators of Sara Solt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Solt. Sara Solt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kouo, Theodore, Lanqing Huang, Alexandra B. Pucsek, et al.. (2015). Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells. Cancer Immunology Research. 3(4). 412–423. 415 indexed citations breakdown →
2.
Whiting, Chan C., Eric R. Lutz, Nitya Nair, et al.. (2015). Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival.. Journal of Clinical Oncology. 33(3_suppl). 261–261. 9 indexed citations
3.
Soares, Kevin C., Agnieszka A. Rucki, Victoria Kim, et al.. (2015). TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner. Oncotarget. 6(40). 43005–43015. 55 indexed citations
4.
Lutz, Eric R., Annie A. Wu, Elaine Bigelow, et al.. (2014). Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation. Cancer Immunology Research. 2(7). 616–631. 399 indexed citations
5.
Le, Dung T., Eric R. Lutz, Jennifer N. Uram, et al.. (2013). Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer. Journal of Immunotherapy. 36(7). 382–389. 437 indexed citations
6.
Le, Dung T., Eric R. Lutz, Lanqing Huang, et al.. (2012). Phase Ib study of ipilimumab alone or in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene (vaccine) in pancreatic cancer.. Journal of Clinical Oncology. 30(4_suppl). 211–211. 4 indexed citations
7.
Yeo, Charles J., Keith D. Lillemoe, Barbara Biedrzycki, et al.. (2011). A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma. Annals of Surgery. 253(2). 328–335. 295 indexed citations
8.
9.
Laheru, Dan, Charles J. Yeo, Barbara Biedrzycki, et al.. (2007). A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas. Journal of Clinical Oncology. 25(18_suppl). 3010–3010. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth Onners Breakdown of academic impact, for papers by Mona Møller Breakdown of academic impact, for papers by Sylvia M. Lee Breakdown of academic impact, for papers by Aniruddha Choudhury Breakdown of academic impact, for papers by Toby Mellows Breakdown of academic impact, for papers by Frank M. Speetjens Breakdown of academic impact, for papers by Isaac Kriley Breakdown of academic impact, for papers by Matilde D’Asaro Breakdown of academic impact, for papers by An Coosemans Breakdown of academic impact, for papers by Gavin Bendle
Rankless by CCL
2026